Qube Research & Technologies LTD Siga Technologies Inc Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.32 - $10.46 $467,029 - $772,962	73,897 Added 120.38%	135,284 $1.03 Million
Q1 2024 May 14, 2024	BUY	$4.51 - $8.92 $65,259 - $129,072	14,470 Added 30.84%	61,387 $525,000
Q4 2023 Feb 13, 2024	SELL	$4.82 - $6.25 $123,936 - $160,706	-25,713 Reduced 35.4%	46,917 $262,000
Q3 2023 Nov 13, 2023	SELL	$4.32 - $5.77 $408,326 - $545,380	-94,520 Reduced 56.55%	72,630 $381,000
Q2 2023 Aug 14, 2023	SELL	$5.0 - $6.31 $488,180 - $616,083	-97,636 Reduced 36.87%	167,150 $844,000
Q1 2023 May 15, 2023	SELL	$5.23 - $8.42 $2.1 Million - $3.39 Million	-402,419 Reduced 60.31%	264,786 $1.52 Million
Q4 2022 Feb 14, 2023	SELL	$7.29 - $10.14 $2.99 Million - $4.16 Million	-410,463 Reduced 38.09%	667,205 $4.91 Million
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $10.5 Million - $27.4 Million	1,048,721 Added 3622.9%	1,077,668 $11.1 Million
Q2 2022 Aug 15, 2022	BUY	$6.5 - $13.68 $188,155 - $395,994	28,947 New	28,947 $335,000
Q1 2022 May 09, 2022	SELL	$5.96 - $7.61 $64,886 - $82,850	-10,887 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$6.96 - $9.26 $75,773 - $100,813	10,887 New	10,887 $82,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.